A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab

J Thorac Oncol. 2020 Jun;15(6):e83-e85. doi: 10.1016/j.jtho.2020.03.021. Epub 2020 Mar 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • China
  • Coronavirus Infections
  • Coronavirus*
  • Humans
  • Lung Neoplasms*
  • Nivolumab
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2
  • Severe acute respiratory syndrome-related coronavirus*

Substances

  • Nivolumab